**
Recent peer-reviewed research has revealed concerning levels of per- and polyfluoroalkyl substances (PFAS), commonly referred to as “forever chemicals,” in the umbilical cord blood of fetuses, suggesting that their exposure is significantly higher than previously understood. A study conducted by Mount Sinai researchers tested 120 umbilical cord blood samples and uncovered 42 distinct PFAS compounds, highlighting an urgent need for revised regulatory measures.
Comprehensive Testing Uncovers New PFAS Compounds
Traditionally, the analysis of umbilical cord blood has focused on a limited selection of PFAS compounds, primarily perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS). However, this new study employed a more extensive “non-targeted analysis” approach. By examining samples that had previously shown only a handful of PFAS, the researchers were able to identify a broader spectrum of chemicals.
The implications of these findings are significant. “Babies are exposed to many more PFAS than we previously thought,” stated Shelley Liu, an associate professor at the Icahn School of Medicine at Mount Sinai and co-author of the study. This expanded identification challenges the scope of current understanding regarding fetal exposure to these hazardous substances.
Understanding the Risks of PFAS Exposure
PFAS are a group of approximately 15,000 synthetic compounds widely used to impart water, stain, and grease resistance to a variety of consumer products. Their persistence in the environment and human body has led to associations with numerous health risks, including cancer, immune dysfunction, and developmental disorders. The term “forever chemicals” stems from their inability to decompose naturally, allowing them to accumulate over time.
Research indicates that elevated levels of PFAS in mothers correlate with adverse outcomes such as increased infant mortality rates, low birth weight, and potential obesity later in childhood. Furthermore, prenatal exposure to these chemicals has been linked to an array of health issues, including neurological impairments and cardiovascular diseases in later life.
Regulatory Challenges and Future Implications
The study’s findings underscore the slow response of regulatory agencies to adapt their testing methods in light of the evolving understanding of PFAS. The U.S. Environmental Protection Agency (EPA), for instance, typically tests for only around 30 to 40 PFAS compounds in water samples, despite independent studies revealing the presence of thousands. A recent analysis indicated that regulatory bodies often underestimate PFAS levels, which raises concerns about the effectiveness of current monitoring strategies.
Mount Sinai’s research illustrates a stark contrast between traditional and comprehensive testing methodologies, revealing that the former often fails to capture the full extent of PFAS contamination. Liu noted that the EPA has recently certified a blood test that checks for 53 PFAS compounds, yet the Mount Sinai study identified 31 additional compounds not included in the EPA’s assessment.
The Health Implications for Newborns
While the study did not directly evaluate health outcomes associated with the increased levels of PFAS detected, it raises pressing questions about their impact. Liu acknowledged that the health ramifications remain “kind of unclear,” but cautioned that higher concentrations of PFAS in blood are generally linked to an elevated risk of health issues.
The blood samples analysed were part of the federal government’s Home study, which tracks individuals’ PFAS exposure and health outcomes over time. Future research by the Mount Sinai team is expected to delve deeper into the potential health implications of these findings.
David Andrews, acting chief science officer at the Environmental Working Group, emphasised the significance of the study, stating, “This paper is a stark reminder of the importance of health-protective regulations and how lax oversight can result in babies being born pre-polluted with harmful chemicals such as PFAS.”
Why it Matters
The revelations from this study highlight a critical public health issue: the pervasive nature of PFAS in the environment and their potential impact on vulnerable populations, particularly developing fetuses. As regulatory frameworks struggle to keep pace with the complexities of chemical exposure, it becomes essential to advocate for more rigorous testing and protective measures to safeguard maternal and infant health. The findings pose urgent questions about the long-term effects of PFAS exposure and underscore an immediate need for heightened awareness and action in both public health and environmental policy.
